Alyeska Investment Group’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-200,873	Closed	-$2.86M	–	451
2016 Q2	$2.86M	Buy	200,873 +18,545	+10%	+$264K	0.03%	342
2016 Q1	$2.64M	Buy	+182,328	New	+$2.64M	0.02%	307